Linked e-resources
Details
Table of Contents
Intro; Acknowledgments; Contents; Contributors; Introduction; Part I: Introduction; 1: Neurobiology of Suicide; Introduction; Epidemiology; Clinical Predictors of Suicidality; Neurobiology; Biomarkers of Suicidality; Serotonin; Noradrenergic System and Suicide; Dopamine; Acetylcholine; Neurotrophins and BDNF; Neuroinflammatory Markers of Suicidality: Evidence of Increased Inflammation in Patients After a Suicide Attempt?; Individual Inflammatory Markers; Cytokines; IL1-B; IL-2; IL-6; TNF-Alpha; IFN-Gamma; C-Reactive Protein; Kynurenic/Quinolinic Acid; S100B
S100B levels ng/mL by BPRS Suicidality Score (Fig. 1.1)Brain-Derived Neurotrophic Factor (BDNF); Vascular Endothelial Growth Factor (VEGF); Orexin; Autoimmunity and Suicide; Infections: Toxoplasma gondii; References; 2: Mood Disorders and Suicide; Introduction; Epidemiology; Etiological Theories; Biological Factors; Psychological Factors; Social/Environmental Factors; Risk Factors; Risk Assessment; Management; Prevention and Treatment; References; 3: Psychosis and Suicide; Overview; Suicide and Schizophrenia; Suicide and First-Episode Psychosis; Risk Factors; Protective Factors; Assessment
Screening MeasuresAssessment Measures; Treatment; Early Intervention; Cognitive Behavioral Therapy; Multisystemic Therapy-Psychiatric; Medications; References; Part II: Special Populations; 4: Suicide in Children; Introduction; Terminology; Epidemiology; Youth Ages 5-11 Years; Youth Ages 10-14 Years; Youth Ages 15-19 Years; Youth Ages 19-24 Years; Risk Factors; Psychopathology; Depression; Previous Suicidal Behavior; Substance Abuse; Family Factors; Familial Transmission of Suicidal Behaviors; Childhood Trauma; Sexual Orientation and Gender Identity; Sexual Orientation; Gender Identity
BullyingAcademic Pressure; Autism Spectrum Disorder (ASD) and/or Intellectual Disabilities (ID); Medical Illness; Implication of Assessment and Management by Risk Factor; Protective Factors; Social Connectedness; Internal Locus of Control; Effective Coping Strategies; Religiosity; Importance of Screening as Means of Prevention; Cultural Considerations; Assessment; Patient Physical Examination; Physical Exam; Laboratory Evaluation; Management; Treatments; Selective Serotonin Reuptake Inhibitors (SSRIs) and Suicidality; Make a Safety Plan with the Patient
Ability to Consent/Legal/ConfidentialityDocumentation; Resources; References; 5: Substance Abuse and Suicide; Introduction; Alcohol Use and Suicide; Opioid Use and Suicide; Cocaine Use and Suicide; References; 6: Suicide in Children and Adults with Epilepsy: A Complex Relationship; Introduction; Prevalence Rates of Suicide and Suicidal Behavior in Epilepsy; Suicide in Adults with Epilepsy; Prevalence Rates of Suicidal Ideation and Suicidal Attempts in Adults with Epilepsy; Prevalence Rates of Suicide, Suicide Attempts, and Suicidal Ideation in Youth with Epilepsy
S100B levels ng/mL by BPRS Suicidality Score (Fig. 1.1)Brain-Derived Neurotrophic Factor (BDNF); Vascular Endothelial Growth Factor (VEGF); Orexin; Autoimmunity and Suicide; Infections: Toxoplasma gondii; References; 2: Mood Disorders and Suicide; Introduction; Epidemiology; Etiological Theories; Biological Factors; Psychological Factors; Social/Environmental Factors; Risk Factors; Risk Assessment; Management; Prevention and Treatment; References; 3: Psychosis and Suicide; Overview; Suicide and Schizophrenia; Suicide and First-Episode Psychosis; Risk Factors; Protective Factors; Assessment
Screening MeasuresAssessment Measures; Treatment; Early Intervention; Cognitive Behavioral Therapy; Multisystemic Therapy-Psychiatric; Medications; References; Part II: Special Populations; 4: Suicide in Children; Introduction; Terminology; Epidemiology; Youth Ages 5-11 Years; Youth Ages 10-14 Years; Youth Ages 15-19 Years; Youth Ages 19-24 Years; Risk Factors; Psychopathology; Depression; Previous Suicidal Behavior; Substance Abuse; Family Factors; Familial Transmission of Suicidal Behaviors; Childhood Trauma; Sexual Orientation and Gender Identity; Sexual Orientation; Gender Identity
BullyingAcademic Pressure; Autism Spectrum Disorder (ASD) and/or Intellectual Disabilities (ID); Medical Illness; Implication of Assessment and Management by Risk Factor; Protective Factors; Social Connectedness; Internal Locus of Control; Effective Coping Strategies; Religiosity; Importance of Screening as Means of Prevention; Cultural Considerations; Assessment; Patient Physical Examination; Physical Exam; Laboratory Evaluation; Management; Treatments; Selective Serotonin Reuptake Inhibitors (SSRIs) and Suicidality; Make a Safety Plan with the Patient
Ability to Consent/Legal/ConfidentialityDocumentation; Resources; References; 5: Substance Abuse and Suicide; Introduction; Alcohol Use and Suicide; Opioid Use and Suicide; Cocaine Use and Suicide; References; 6: Suicide in Children and Adults with Epilepsy: A Complex Relationship; Introduction; Prevalence Rates of Suicide and Suicidal Behavior in Epilepsy; Suicide in Adults with Epilepsy; Prevalence Rates of Suicidal Ideation and Suicidal Attempts in Adults with Epilepsy; Prevalence Rates of Suicide, Suicide Attempts, and Suicidal Ideation in Youth with Epilepsy